BBristol Read More Why Bristol Myers, Johnson & Johnson and More Are Watching Seaport After IPO22 August 2026 Quick Read SPTX’s Glyph prodrug platform has generated 24 candidates, with lead asset GlyphAllo entering Phase 2b for…